Skip to main content
SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD logo

SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 002737 ISIN · CNE100001WT7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,264 across all filing types
Latest filing 2018-04-19 Share Issue/Capital Cha…
Country CN China
Listing Shenzhen Stock Exchange 002737

About SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD

https://www.kuihuayaoye.com

Sunflower Pharmaceutical Group Co., Ltd. focuses on the research, development, manufacturing, and distribution of proprietary Chinese medicines, chemical drugs, and health supplements. The organization is particularly noted for its specialization in pediatric medicine, marketed under the "Little Sunflower" brand, which includes treatments for respiratory and digestive ailments. Its extensive product portfolio also covers gynecological health and general internal medicine. The group operates several integrated production bases and research institutes, facilitating a comprehensive approach to drug formulation and quality control. By leveraging a robust supply chain and a wide-reaching distribution network, the company provides a diverse range of over-the-counter and prescription solutions aimed at improving family health and wellness.

Recent filings

Filing Released Lang Actions
关于办理完成工商变更登记的公告
Share Issue/Capital Change Classification · 95% confidence The document is an official announcement from a listed company (葵花药业集团股份有限公司) regarding the completion of a business registration change. It details the approval of a profit distribution plan and a capital increase through a share bonus, resulting in a change in registered capital and amendments to the company's articles of association. It also mentions the issuance of a new business license reflecting these changes. The document includes references to board and shareholder meeting resolutions but does not contain financial statements or detailed financial performance data. The length is short (1346 characters), and the content is focused on corporate registration and capital change announcements rather than a full report or financial results. Therefore, this is best classified as a Share Issue/Capital Change announcement (SHA).
2018-04-19 Chinese
公司章程（2018年4月）
Governance Information Classification · 100% confidence The document is titled as the Articles of Association (章程) of 葵花药业集团股份有限公司 (Sunflower Pharmaceutical Group Co., Ltd.) dated April 2018. It contains detailed provisions about the company's organization, shareholder rights, board of directors, management, share issuance, shareholder meetings, voting procedures, and other governance-related rules. There is no indication of financial statements, audit opinions, earnings data, or other financial performance information. The content is focused on the company's internal rules and governance structure. Therefore, this document fits the category of Governance Information (CGR). The document length is substantial (15,000 characters), indicating it is the full text of the governance document, not just an announcement or summary.
2018-04-19 Chinese
关于使用自有资金设立全资子公司的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by a company (葵花药业集团股份有限公司) regarding the use of its own funds to establish a wholly-owned subsidiary. It details the investment amount, purpose, approval process, and potential risks. There is no financial data, no mention of a report being attached or published, and no indication of regulatory certifications or voting results. The content is about a capital investment and company structure change related to financing activities. Therefore, the document fits best under the category of Capital/Financing Update (CAP). The document length is short (1574 characters), but it is not a mere announcement of a report publication or certification, so it is not RPA or RNS.
2018-04-16 Chinese
第三届董事会第六次会议决议公告
Board/Management Information Classification · 100% confidence The document is a formal announcement of the resolutions passed at the sixth meeting of the third board of directors of the company. It includes details about the meeting date, method, attendance, and voting results on a specific agenda item (establishment of a subsidiary). There is no financial data, no mention of annual or quarterly reports, no audit information, and no regulatory filings or certifications. The content focuses on board decisions and approvals, which fits the category of Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication but a direct announcement of board resolutions.
2018-04-16 Chinese
关于公司实际控制人部分股份解除质押公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding the release of pledged shares by the company's actual controller, including details about the number of shares released from pledge, dates, and related parties. It does not contain financial statements, management discussion, or detailed financial data. The document is short (1156 characters) and serves as a regulatory disclosure about share pledge status changes. This fits the category of a Regulatory Filing (RNS), which covers miscellaneous regulatory announcements that do not fit other specific categories.
2018-04-13 Chinese
2017年年度权益分派实施公告
Notice of Dividend Amount Classification · 100% confidence The document is an announcement regarding the implementation of the 2017 annual equity distribution plan by the company 葵花药业集团股份有限公司. It details the dividend distribution, share capital increase through capital reserve conversion, record dates, ex-dividend dates, and related shareholder information. The document includes specifics on dividend amounts, share transfer procedures, and adjustments to shareholding and lock-up commitments. It is not a full annual report or financial statement but rather a formal announcement of dividend and share distribution details following shareholder approval at the annual general meeting. This fits the definition of a Notice of Dividend Amount (DIV) filing, as it announces dividend amounts, payment dates, and related shareholder distribution details.
2018-04-11 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.